Atek Bio

Atek Bio

阿泰克生物

Atek Bio

Biotech/Healthcare

Atec focuses on developing globally novel, next-generation protein degradation drugs. The company is pursuing a differentiated approach centered on small-molecule glue drugs that induce targeted degradation through the autophagy-lysosome pathway, with the aim of providing new treatments for…

Latest round: Series B (2026)

Source: ChinaBulls — chinabulls.com

Last updated 2026-10-30

Funding history

Request access to view this section.

Investors

Request access to view this section.

HQ & website

Request access to view this section.

Tags

Request access to view this section.